Silicon Valley Medical Technologies
1. What specific items of capital should be included in the SIVMED’s WACC? Should before-tax or after-tax values be included? Should historical or new values be used? Why?
Answer: WACC covers computation of SIVMED’s cost of capital in which each category of capital is proportionately weighted. All capital basis - common stock, preferred stock, bonds or any other long-term borrowings – should be listed under SIVMED’s WACC. We determine WACC by multiplying the cost of the corresponding capital component by its proportional weight and then adding: where: Re is a cost of equity Rd is a cost of debt E is a market value of the firm's equity D is a market value of the firm's debt V equals E + D E/V is a proportion of financing that is equity D/V is a proportion of financing that is debt Tc is a corporate tax rate Broadly speaking, SIVMED’s assets are financed by the choice of debt or equity. WACC is the average of the costs of these sources of financing, each of which is weighted by its respective use in the given situation. By taking a weighted average, SIVMED can determine how much interest the company has to pay for every dollar it uses. Shareholders are interested into cash flows available to them, after corporate taxes have been paid. Consequently, we have to use After-Tax WACC. The cost of capital is used above all to make decisions that involve getting new capital. Hence, the applicable component costs are present marginal costs but not than historical costs.
2. What is your estimate of SIVMED’s cost of debt?
a. The cost of debt is the money company has to pay for using the funds. In our case, annual cost of debt is kd: kd/2 = r = 5.0%. kd/2 = (47.5 + [1000-891] / 30) / ((2*891 + 1000) / 3) = 5.5% We have to multiply this by 2 since we are dealing with semiannual payments, hence annual yield is 11%. Because interest is tax deductible, government pays part of the cost, and our component cost of debt is the after tax cost: kd (1-T) = 11% (1-0.4) = 11 *
Answer: WACC covers computation of SIVMED’s cost of capital in which each category of capital is proportionately weighted. All capital basis - common stock, preferred stock, bonds or any other long-term borrowings – should be listed under SIVMED’s WACC. We determine WACC by multiplying the cost of the corresponding capital component by its proportional weight and then adding: where: Re is a cost of equity Rd is a cost of debt E is a market value of the firm's equity D is a market value of the firm's debt V equals E + D E/V is a proportion of financing that is equity D/V is a proportion of financing that is debt Tc is a corporate tax rate Broadly speaking, SIVMED’s assets are financed by the choice of debt or equity. WACC is the average of the costs of these sources of financing, each of which is weighted by its respective use in the given situation. By taking a weighted average, SIVMED can determine how much interest the company has to pay for every dollar it uses. Shareholders are interested into cash flows available to them, after corporate taxes have been paid. Consequently, we have to use After-Tax WACC. The cost of capital is used above all to make decisions that involve getting new capital. Hence, the applicable component costs are present marginal costs but not than historical costs.
2. What is your estimate of SIVMED’s cost of debt?
a. The cost of debt is the money company has to pay for using the funds. In our case, annual cost of debt is kd: kd/2 = r = 5.0%. kd/2 = (47.5 + [1000-891] / 30) / ((2*891 + 1000) / 3) = 5.5% We have to multiply this by 2 since we are dealing with semiannual payments, hence annual yield is 11%. Because interest is tax deductible, government pays part of the cost, and our component cost of debt is the after tax cost: kd (1-T) = 11% (1-0.4) = 11 *